cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
/PRNewswire/ -- cTRL Therapeutics, a biotechnology company harnessing circulating tumor-reactive lymphocytes (cTRLs) in the blood to broaden the power and...
Stay updated with breaking news from Cellevolve Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- cTRL Therapeutics, a biotechnology company harnessing circulating tumor-reactive lymphocytes (cTRLs) in the blood to broaden the power and...
The global progressive multifocal leukoencephalopathy treatment market is expected to garner a market value of US$ 1,320 million in 2023 and is expected to accumulate a market value of US$ 1,773.97 million by registering a CAGR of 3% in the forecast period 2023 to 2033. The market for progressive multifocal leukoenc...
/PRNewswire/ -- Cellevolve Bio, Inc. ("the Company" or "Cellevolve"), a clinical stage development and commercialization platform company focused on cell...
/PRNewswire/ -- Cellevolve Bio, Inc. ("the Company" or "Cellevolve"), a development and commercialization platform company focused on cell therapies, today...
Black students are a minority in the life sciences and biotechnology. A Black female scientist and entrepreneur talks about why and how this should change.